Charmacy Pharmaceutical Co., Ltd. (HKG:2289)

Hong Kong · Delayed Price · Currency is HKD

5.50

-0.01 (-0.09%)

Sep 9, 2026, 6:07 PM HKT

Market Cap	593.46M -5.7%
Revenue (ttm)	5.40B +10.2%
Net Income	54.36M -2.5%
EPS	0.50 -2.5%
Shares Out	108.00M
PE Ratio	10.92
Forward PE	n/a
Dividend	0.35 (6.37%)
Ex-Dividend Date	May 27, 2026

Volume	500
Open	5.50
Previous Close	5.50
Day's Range	5.50 - 5.50
52-Week Range	4.30 - 7.40
Beta	-0.97
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 1, 2026

About Charmacy Pharmaceutical

Charmacy Pharmaceutical Co., Ltd. engages in the pharmaceutical distribution business in the People’s Republic of China. It distributes western medicines, Chinese patent medicines, healthcare products, and pharmaceutical products to downstream distributors and retail terminals. The company also offers pharmaceutical product related consulting services; and operates Charmacy e-Medicine, a B2B e-commerce platform to place orders online, make inquires, and payments, etc. The company was formerly known as Chuangmei Pharmaceutical Co., Ltd. and chan... [Read more]

Industry Medical Distribution

Sector Healthcare

Founded 1984

Employees 827

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 2289

Full Company Profile

Financial Performance

In 2025, Charmacy Pharmaceutical's revenue was 4.38 billion, a decrease of -1.15% compared to the previous year's 4.44 billion. Earnings were 46.27 million, a decrease of -13.16%.

Financial numbers in CNY Financial Statements